Staphylococcus Aureus

Infectious Disease·MeSH: Staphylococcal Infections

21 drugs in development·17 companies·2 clinical trials

Drug Pipeline by Phase

Approved(14)

Drug	Company
amoxicillin	SUNSET ISLAND GROUP (SUN)
amoxicillin	Aptinyx Inc. (APTX)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
daptomycin	MAIA Biotechnology, Inc. (MAIA)
sivextro	Curative Biotechnology Inc (CUBT)
Xepi®	Biofrontera Inc. (BFRI)
zevtera	Innoviva, Inc. (INVA)
ZEVTERA®	Innoviva, Inc. (INVA)

Phase 3(3)

Drug	Company
AR-301	Aridis Pharmaceuticals, Inc. (ARDS)
AR-320	Aridis Pharmaceuticals, Inc. (ARDS)
AZD7760	ASTRAZENECA PLC (AZN)

Preclinical(2)

Drug	Company
mrsa therapeutic	XBiotech Inc. (XBIT)
nano-mupirocin	Revium Rx. (RVRC)

Unknown(1)

Drug	Company
exebacase	CONTRAFECT Corp (CFRX)

Phase 1/Phase 2(1)

Drug	Company
514g3 plus standard iv antibiotic treatment	XBiotech Inc. (XBIT)

BioSniper tracks 21 drugs in development for Staphylococcus Aureus across 17 companies.

There are 2 clinical trials targeting Staphylococcus Aureus tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.